SG141382A1 - Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
SG141382A1
SG141382A1 SG200708582-2A SG2007085822A SG141382A1 SG 141382 A1 SG141382 A1 SG 141382A1 SG 2007085822 A SG2007085822 A SG 2007085822A SG 141382 A1 SG141382 A1 SG 141382A1
Authority
SG
Singapore
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
tetracyclic compounds
compounds
Prior art date
Application number
SG200708582-2A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Christophe Poitevin
Mark Millan
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG141382A1 publication Critical patent/SG141382A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG200708582-2A 2006-09-26 2007-09-24 Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them SG141382A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608413A FR2906249B1 (fr) 2006-09-26 2006-09-26 Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SG141382A1 true SG141382A1 (en) 2008-04-28

Family

ID=37877016

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200708582-2A SG141382A1 (en) 2006-09-26 2007-09-24 Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US7470683B2 (pt)
EP (1) EP1905775B1 (pt)
JP (1) JP2008100995A (pt)
KR (1) KR100934315B1 (pt)
CN (1) CN101153043B (pt)
AR (1) AR062950A1 (pt)
AT (1) ATE480544T1 (pt)
AU (1) AU2007219281A1 (pt)
BR (1) BRPI0703655A2 (pt)
CA (1) CA2603274C (pt)
CY (1) CY1110799T1 (pt)
DE (1) DE602007009004D1 (pt)
DK (1) DK1905775T3 (pt)
EA (1) EA013406B1 (pt)
ES (1) ES2351945T3 (pt)
FR (1) FR2906249B1 (pt)
GE (1) GEP20104877B (pt)
HK (1) HK1119163A1 (pt)
HR (1) HRP20100605T1 (pt)
MA (1) MA29371B1 (pt)
MX (1) MX2007011524A (pt)
MY (1) MY142517A (pt)
NO (1) NO20074889L (pt)
NZ (1) NZ561905A (pt)
PL (1) PL1905775T3 (pt)
PT (1) PT1905775E (pt)
RS (1) RS51418B (pt)
SG (1) SG141382A1 (pt)
SI (1) SI1905775T1 (pt)
UA (1) UA96125C2 (pt)
WO (1) WO2008037888A2 (pt)
ZA (1) ZA200708215B (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
FR2721027B1 (fr) 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) * 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2767825A1 (fr) * 1997-09-01 1999-02-26 Adir Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2845994B1 (fr) * 2002-10-18 2006-05-19 Servier Lab Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HK1119163A1 (en) 2009-02-27
KR100934315B1 (ko) 2009-12-29
EA200701807A1 (ru) 2008-04-28
EP1905775A1 (fr) 2008-04-02
MX2007011524A (es) 2009-02-16
MY142517A (en) 2010-12-15
CN101153043B (zh) 2011-01-19
US7470683B2 (en) 2008-12-30
PT1905775E (pt) 2010-11-17
CY1110799T1 (el) 2015-06-10
DK1905775T3 (da) 2010-12-06
EP1905775B1 (fr) 2010-09-08
CN101153043A (zh) 2008-04-02
SI1905775T1 (sl) 2010-10-29
AU2007219281A1 (en) 2008-04-10
FR2906249A1 (fr) 2008-03-28
RS51418B (en) 2011-02-28
BRPI0703655A2 (pt) 2009-05-19
US20080076765A1 (en) 2008-03-27
PL1905775T3 (pl) 2011-03-31
JP2008100995A (ja) 2008-05-01
EA013406B1 (ru) 2010-04-30
KR20080028316A (ko) 2008-03-31
NO20074889L (no) 2008-03-27
NZ561905A (en) 2009-01-31
CA2603274A1 (fr) 2008-03-26
ATE480544T1 (de) 2010-09-15
ES2351945T3 (es) 2011-02-14
WO2008037888A2 (fr) 2008-04-03
GEP20104877B (en) 2010-01-11
AR062950A1 (es) 2008-12-17
WO2008037888A3 (fr) 2008-06-12
FR2906249B1 (fr) 2008-12-19
DE602007009004D1 (de) 2010-10-21
UA96125C2 (ru) 2011-10-10
ZA200708215B (en) 2008-09-25
HRP20100605T1 (hr) 2010-12-31
MA29371B1 (fr) 2008-04-01
CA2603274C (fr) 2010-08-31

Similar Documents

Publication Publication Date Title
MX2021008356A (es) Inhibidores de jak2 y alk2 y metodos para su uso.
WO2012054110A3 (en) Compounds and methods for inhibiting phosphate transport
JO2673B1 (en) Diosmetin compounds, method of preparation and pharmaceutical compositions
MX2011012122A (es) Derivados de tiofeno.
HK1167607A1 (en) Quinoline derivative-containing pharmaceutical composition
EP2590655A4 (en) COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
MX2009011802A (es) Imidazoquinolinas con propiedades inmunomoduladoras.
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
MX2013003019A (es) Compuestos de azabenzotiazol, composiciones y metodos de uso.
WO2012006474A3 (en) Compounds and methods for inhibiting phosphate transport
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
SG168499A1 (en) New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
NZ603465A (en) Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient
MX345544B (es) Derivados de triazol como ligandos para receptores de acido gamma-aminobutirico (gaba).
WO2008049997A8 (fr) Derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA98639C2 (en) Phosphodiesterase inhibitors
MX2013005965A (es) Nuevos compuestos de triazol iii.
SG141382A1 (en) Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
WO2009137130A3 (en) Antibacterial fluoroquinolone analogs
UA91646C2 (ru) Соединения индола, способ их получения и фармацевтическая композиция (варианты), которая их содержит
JO2948B1 (en) New dihydro-oxazole openzo-2-azipenone compounds, their preparation and pharmaceutical compounds
SG168483A1 (en) New piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
MX2009005250A (es) Compuestos 2-alquil-indazol para el tratamiento de ciertas enfermedades relacionadas con el sistema nervioso central (cns).
SG153774A1 (en) New 1h-indol-1-yl-urea compounds, a process for their preparation and pharmaceutical compositions containing them
TN2010000324A1 (en) New piperidine compounds a process for their preparation and pharmaceutical compositions containing them